Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Pneumococcal Polysaccharide Vaccine Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Pneumococcal Polysaccharide Vaccine Industry
  • 1.7 COVID-19 Impact: Pneumococcal Polysaccharide Vaccine Market Trends

    • 2 Global Pneumococcal Polysaccharide Vaccine Quarterly Market Size Analysis

    • 2.1 Pneumococcal Polysaccharide Vaccine Business Impact Assessment - COVID-19
      • 2.1.1 Global Pneumococcal Polysaccharide Vaccine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Pneumococcal Polysaccharide Vaccine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Pneumococcal Polysaccharide Vaccine Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Pneumococcal Polysaccharide Vaccine Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Pneumococcal Polysaccharide Vaccine Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Pneumococcal Polysaccharide Vaccine Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
    • 3.5 Key Manufacturers Pneumococcal Polysaccharide Vaccine Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Pneumococcal Polysaccharide Vaccine Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Single Dose Vial
      • 1.4.2 Pre-Filled Syringe
    • 4.2 By Type, Global Pneumococcal Polysaccharide Vaccine Market Size, 2019-2021
      • 4.2.1 By Type, Global Pneumococcal Polysaccharide Vaccine Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Pneumococcal Polysaccharide Vaccine Price, 2020-2021

    5 Impact of Covid-19 on Pneumococcal Polysaccharide Vaccine Segments, By Application

    • 5.1 Overview
      • 5.5.1 Children (2-10 Age)
      • 5.5.2 Adult (10-64 Age)
      • 5.5.3 Geriatric (More Than 65 Age)
    • 5.2 By Application, Global Pneumococcal Polysaccharide Vaccine Market Size, 2019-2021
      • 5.2.1 By Application, Global Pneumococcal Polysaccharide Vaccine Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Pneumococcal Polysaccharide Vaccine Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Merck & Co., Inc.
      • 7.1.1 Merck & Co., Inc. Business Overview
      • 7.1.2 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.1.4 Merck & Co., Inc. Response to COVID-19 and Related Developments
    • 7.2 Pfizer Inc.
      • 7.2.1 Pfizer Inc. Business Overview
      • 7.2.2 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.2.4 Pfizer Inc. Response to COVID-19 and Related Developments
    • 7.3 Glaxosmithkline Plc.
      • 7.3.1 Glaxosmithkline Plc. Business Overview
      • 7.3.2 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.3.4 Glaxosmithkline Plc. Response to COVID-19 and Related Developments
    • 7.4 Sanofi Pasteur
      • 7.4.1 Sanofi Pasteur Business Overview
      • 7.4.2 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.4.4 Sanofi Pasteur Response to COVID-19 and Related Developments
    • 7.5 China National Biotec Group
      • 7.5.1 China National Biotec Group Business Overview
      • 7.5.2 China National Biotec Group Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.5.4 China National Biotec Group Response to COVID-19 and Related Developments
    • 7.6 Astellas Pharma Inc
      • 7.6.1 Astellas Pharma Inc Business Overview
      • 7.6.2 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.6.4 Astellas Pharma Inc Response to COVID-19 and Related Developments
    • 7.7 Serum Institute of India Pvt. Ltd
      • 7.7.1 Serum Institute of India Pvt. Ltd Business Overview
      • 7.7.2 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.7.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.7.4 Serum Institute of India Pvt. Ltd Response to COVID-19 and Related Developments
    • 7.8 MSD
      • 7.8.1 MSD Business Overview
      • 7.8.2 MSD Pneumococcal Polysaccharide Vaccine Quarterly Production and Revenue, 2020
      • 7.8.3 MSD Pneumococcal Polysaccharide Vaccine Product Introduction
      • 7.8.4 MSD Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
      • 8.1.1 Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Pneumococcal Polysaccharide Vaccine Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Pneumococcal Polysaccharide Vaccine Distribution Channels
      • 8.2.2 Covid-19 Impact on Pneumococcal Polysaccharide Vaccine Distribution Channels
      • 8.2.3 Pneumococcal Polysaccharide Vaccine Distributors
    • 8.3 Pneumococcal Polysaccharide Vaccine Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Pneumococcal Polysaccharide Vaccine, including the following market information:
      Global Pneumococcal Polysaccharide Vaccine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Pneumococcal Polysaccharide Vaccine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Pneumococcal Polysaccharide Vaccine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Pneumococcal Polysaccharide Vaccine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Merck & Co., Inc., Pfizer Inc., Glaxosmithkline Plc., Sanofi Pasteur, China National Biotec Group, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd, MSD, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Single Dose Vial
      Pre-Filled Syringe

      Based on the Application:
      Children (2-10 Age)
      Adult (10-64 Age)
      Geriatric (More Than 65 Age)

      Buy now